LPL Financial »

Brainstorm Cell Therapeutics shares owned by LPL Financial

Quarter-by-quarter ownership of Brainstorm Cell Therapeutics (BCLI) shares owned by LPL Financial from 13F filings

Historical chart of LPL Financial investment in Brainstorm Cell Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Brainstorm Cell Therapeutics held by LPL Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Brainstorm Cell Therapeutics by LPL Financial

Quarter filed Position value Share count Share price at filing
2023-09-30 $8.3k 41k 0.20
2023-06-30 $86k 42k 2.06
2016-03-31 $27k 10k 2.70
2015-12-31 $31k 10k 3.10

More positions owned by LPL Financial

Ishares Tr Core S&p500 Etf (IVV)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Ishares Tr Core Msci Eafe (IEFA)
Ishares Tr Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Ishares Tr Msci Usa Qlt Fct (QUAL)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Ishares Tr Mbs Etf (MBB)
Spdr Ser Tr Prtflo S&p500 Gw (SPYG)
Ishares Tr Core S&p Us Gwt (IUSG)
Vanguard Index Fds Growth Etf (VUG)

View all positions for LPL Financial

Top funds holding Brainstorm Cell Therapeutics

Vanguard Group
Liberty Wealth Management
Weaver Consulting Group
Caldwell Sutter Capital
Abner, Herrman & BrocK
Raymond James & Associates
ADAR1 Capital Management
Ikarian Capital
Kingswood Wealth Advisors
Citadel Advisors
Virtu Financial
Jmac Enterprises
Barclays
Wells Fargo & Company
Saxony Capital Management

View all funds holding Brainstorm Cell Therapeutics